Gastroenterology

Gastroenterology

Volume 128, Issue 2, February 2005, Pages 351-360
Gastroenterology

Basic-alimentary tract
Linkage to peroxisome proliferator-activated receptor-γ in SAMP1/YitFc mice and in human Crohn’s disease

https://doi.org/10.1053/j.gastro.2004.11.001Get rights and content

Background & Aims: Genetic predisposition is implicated strongly in Crohn’s disease. Disease-associated mutations in NOD2/CARD15, the best-studied susceptibility gene in this disorder, explain only a small fraction of the heritability. The SAMP1/YitFc (SAMP1/Fc) mouse strain expresses many features of Crohn’s disease in humans. We bred SAMP1/Fc to disease-resistant AKR mice to identify additional susceptibility genes that may play a role in human disease. Methods: Linkage disequilibrium mapping was performed in an (AKR × SAMP1/Fc) backcross to SAMP1/Fc, followed by sequencing, expression analysis using reverse transcription polymerase chain reaction (PCR) and immunohistochemistry, and functional testing in vivo of the regional candidate gene encoding the peroxisome proliferator-activated receptor γ (Pparg). A cohort-based association study was performed in humans. Results: We show that ileitis is blocked in SAMP1/Fc mice by inheritance of AKR alleles on chromosome 6 in the region of Pparg. Major differences in Pparγ expression in the parental mouse strains are found specifically in the crypts of the small intestine, and treatment of ileitis-prone mice with a Pparγ agonist decreased disease severity in susceptible mice expressing low levels of the protein. Rare alleles of PPARG are associated significantly with Crohn’s disease in humans. Conclusions: We have identified Pparg as a susceptibility gene in both the SAMP/Yit mouse and in human Crohn’s disease. Similarities between Crohn’s disease and the SAMP1/Fc model suggest that the effect of this gene in humans may be mediated through regulation of PPARγ activity in the crypts of the small intestine.

Section snippets

Animals

SAMP1/Yit mice1 have been propagated as a specific pathogen-free colony for more than 20 generations under protocols approved by the Institutional Animal Care and Use Committee following American Association of Accreditation of Laboratory Animal Care guidelines. We now distinguish this line from the original strain as SAMP1/YitFc.4 AKR/J (AKR) mice were purchased from The Jackson Laboratory (Bar Harbor, ME). Female AKR and (AKR × SAMP1/Fc)F1 mice bred to male SAMP1/Fc mice produced F1 and

Histologic analysis suggests a dominant protective effect at a single locus by AKR alleles

Ileitis of variable severity is found in nearly all SAMP1/Fc mice after 10 weeks of age (total inflammatory score: median, 11.25; range, 1.5–16.5; n = 16), and the lesions persist throughout the remaining life of the mice.1, 2, 3, 4 In contrast, AKR mice display little evidence of inflammation (range of total inflammatory scores, .25–1.5 by 30 weeks of age; n = 4), even after sharing cages with SAMP1/Fc mice for >3 months before examination. Similarly, we found little evidence of inflammation

Discussion

We have shown that allelic differences in Pparg can regulate expression of an underlying genetic susceptibility to Crohn’s-like ileitis in mice. We also have shown that minor allelic variants of PPARG are associated strongly with disease resistance in humans. Other groups have proposed that PPARγ plays a role in susceptibility to inflammatory bowel disease in humans (reviewed in Daynes and Jones16), and we now show positive evidence for association with Crohn’s disease. PPARG maps to 3(p25–p26)

References (37)

  • L. Dubuquoy et al.

    Role of peroxisome proliferator-activated receptor gamma and retinoid X receptor heterodimer in hepatogastroenterological diseases

    Lancet

    (2002)
  • M. Kinoshita et al.

    Butyrate reduces colonic paracellular permeability by enhancing PPARgamma activation

    Biochem Biophys Res Commun

    (2002)
  • L. Dubuquoy et al.

    Impaired expression of peroxisome proliferators-activated receptor γ in ulcerative colitis

    Gastroenterology

    (2003)
  • S. Lala et al.

    Crohn’s disease and the NOD2 genea role for Paneth cells

    Gastroenterology

    (2003)
  • K. Katayama et al.

    A novel PPAR gamma gene therapy to control inflammation associated with inflammatory bowel disease in a murine model

    Gastroenterology

    (2003)
  • S. Matsumoto et al.

    Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse SAMP1/Yit strain

    Gut

    (1998)
  • M.M. Kosiewicz et al.

    Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn’s disease

    J Clin Invest

    (2001)
  • T.T. Pizarro et al.

    Lessons from genetically engineered animal models. XI. Novel mouse models to study pathogenic mechanisms of Crohn’s disease

    Am J Physiol

    (2000)
  • Cited by (0)

    Supported by the National Institute of Digestive, Diabetes, and Kidney Diseases (PO1 DK57880), the Crohn’s and Colitis Foundation (to K.S.), and the Uehara Memorial Foundation (to K.K.).

    View full text